Evidence map›Paper›PMID 27419216›Full record

ArticleeNeuro

Long-Term Treatment with Low Doses of Methamphetamine Promotes Neuronal Differentiation and Strengthens Long-Term Potentiation of Glutamatergic Synapses onto Dentate Granule Neurons.

Sofia Baptista, Joana Lourenço, Nuno Milhazes, Fernanda Borges, Ana Paula Silva, Alberto Bacci

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Sofia BaptistaInstitute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal; Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal; Sorbonne Universités, Université Pierre et Marie Curie, Unité Mixte de Recherche (UMR) S 1127, Institut National de la Santé et de la Recherche Médicale U 1127, Centre National de la Recherche Scientifique UMR 7225, and Institut du Cerveau et de la Moelle épinière, 75013 Paris, France.ORCID 0000-0002-2230-5687
Joana LourençoSorbonne Universités, Université Pierre et Marie Curie, Unité Mixte de Recherche (UMR) S 1127, Institut National de la Santé et de la Recherche Médicale U 1127, Centre National de la Recherche Scientifique UMR 7225, and Institut du Cerveau et de la Moelle épinière , 75013 Paris, France.ORCID 0000-0001-5550-9291
Nuno MilhazesInstitute of Health Sciences-North, 4585-116 Gandra, Portugal; Department of Chemistry and Biochemistry, Faculty of Sciences, Centro de Investigação em Química da Universidade do Porto, 4169-007 Porto, Portugal.
Fernanda BorgesDepartment of Chemistry and Biochemistry, Faculty of Sciences, Centro de Investigação em Química da Universidade do Porto , 4169-007 Porto, Portugal.ORCID 0000-0003-1050-2402
Ana Paula SilvaInstitute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal; Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0002-7802-8690
Alberto BacciSorbonne Universités, Université Pierre et Marie Curie, Unité Mixte de Recherche (UMR) S 1127, Institut National de la Santé et de la Recherche Médicale U 1127, Centre National de la Recherche Scientifique UMR 7225, and Institut du Cerveau et de la Moelle épinière , 75013 Paris, France.
Sorbonne Université · FRUniversidade do Porto · PTUniversity of Coimbra · PT

Funding

European Research Council 200808
6 · The paper itself

Abstract

Methamphetamine (METH) is a psychostimulant, affecting hippocampal function with disparate cognitive effects, which depends on the dose and time of administration, ranging from improvement to impairment of memory. Importantly, in the United States, METH is approved for the treatment of attention deficit hyperactivity disorder. Modifications of long-term plasticity of synapses originating from the entorhinal cortex onto dentate granule cells (DGCs) have been proposed to underlie cognitive alterations similar to those seen in METH users. However, the effects of METH on synaptic plasticity of the dentate gyrus are unknown. Here, we investigated the impact of long-term administration of METH (2 mg/kg/d) on neurogenesis and synaptic plasticity of immature and mature DGCs of juvenile mice. We used a mouse model of neurogenesis (the G42 line of GAD67-GFP), in which GFP is expressed by differentiating young DGCs. METH treatment enhanced the differentiation of GFP(+) cells, as it increased the fraction of GFP(+) cells expressing the neuronal marker NeuN, and decreased the amount of immature DGCs coexpressing doublecortin. Interestingly, METH did not change the magnitude of long-term potentiation (LTP) in more immature neurons, but facilitated LTP induction in more differentiated GFP(+) and strengthened plasticity in mature GFP(-) DGCs. The METH-induced facilitation of LTP in GFP(+) neurons was accompanied with spine enlargement. Our results reveal a specific action of long-term use of METH in the long-term plasticity of excitatory synapses onto differentiating DGCs and might have important implications toward the understanding of the synaptic basis of METH-induced cognitive alterations.

Indexed as

AnimalsCentral Nervous System StimulantsDentate GyrusDNA-Binding ProteinsDoublecortin Domain ProteinsGlutamate DecarboxylaseGreen Fluorescent ProteinsImmunohistochemistryLong-Term PotentiationMaleMethamphetamineMice, Inbred C57BLMice, TransgenicMicroelectrodesMicroscopy, ConfocalMicrotubule-Associated ProteinsCentral Nervous System StimulantsDNA-Binding ProteinsDoublecortin Domain ProteinsGlutamate Decarboxylaseglutamate decarboxylase 1Green Fluorescent ProteinsMethamphetamineMicrotubule-Associated ProteinsNerve Tissue ProteinsNeuN protein, mouseNeuropeptidesNuclear ProteinsADHDdentate gyrusmethamphetamineneurogenesissynaptic plasticity

Identifiers

PMID27419216
PMCPMC4939399
OpenAlexW2473063342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.